基于超声影像组学机器学习模型预测附件肿块恶性风险
本研究回顾性纳入2073例附件肿块患者,开发基于超声影像组学特征的机器学习模型鉴别良恶性,并与ADNEX模型比较。验证集中极端梯度提升临床-影像组学模型AUC为0.89,低于ADNEX模型的0.95。
要点
- 临床-影像组学模型验证集AUC为0.89,敏感度0.83,特异度0.81。
- ADNEX模型验证集AUC为0.95,10%阈值下敏感度0.97、特异度0.72。
- 影像组学模型性能未优于ADNEX,需外部验证。
核心结论
- 基于超声的影像组学模型可用于鉴别附件肿块良恶性,但验证集性能低于ADNEX模型,支持在更大样本中进一步探索影像组学分析。
研究设计与样本
- 回顾性、观察性、单中心研究,纳入2012年1月至2023年12月意大利罗马Gemelli IRCCS基金会医院超声检查的附件肿块患者,最终分析2073例,按7:3随机分层分为训练集和验证集。
主要发现
- 验证集(n=622,含254例恶性)中,极端梯度提升临床-影像组学模型(纳入年龄、血清CA 125及14个影像组学特征)AUC为0.89(95%CI 0.86-0.92),最优截断点(31%恶性风险)下敏感度0.83(95%CI 0.79-0.88)、特异度0.81(95%CI 0.77-0.85)。
- 该模型在10%恶性风险截断点下敏感度0.94(95%CI 0.91-0.97)、特异度0.48(95%CI 0.42-0.53)。
- ADNEX模型在验证集10%恶性风险截断点下AUC为0.95(95%CI 0.93-0.97),敏感度0.97(95%CI 0.95-0.99),特异度0.72(95%CI 0.68-0.77)。
关键数值与推荐
- 影像组学模型最优截断点为31%恶性风险(基于Youden指数);ADNEX模型采用10%恶性风险截断点(临床推荐阈值)。
临床怎么用
- 影像组学模型在10%阈值下敏感度高但特异度低,ADNEX模型综合判别性能更优,当前影像组学模型尚不能替代ADNEX用于临床决策。
局限性
- 回顾性单中心研究,排除了大量无合适超声图像的患者,每个肿瘤仅使用一张图像,未进行外部验证,需在更大样本和外部人群中验证泛化性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The primary aim of this study was to develop and internally validate ultrasound-based radiomics models to discriminate between all types of benign and malignant adnexal masses. The secondary aim was to compare the performance of the radiomics models with that of the Assessment of Different NEoplasias in the adneXa (ADNEX) model. METHODS: This was a retrospective, observational, single-center study, for which all patients with an adnexal mass that were included in the ongoing International Ovarian Tumor Analysis phase-5 and phase-7 studies and were examined using ultrasound between January 2012 and December 2023 at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy, were eligible for inclusion. Inclusion criteria were: adnexal mass detected by ultrasound; surgical removal of the adnexal mass within 180 days after the ultrasound examination; histological confirmation of an adnexal mass; and absence of a synchronous malignant tumor. Patients without digital ultrasound images saved in DICOM format were excluded. The patient cohort was split randomly into training and validation sets using a stratified split with a ratio of 70:30, to preserve the proportion of benign and malignant cases in the two sets. Two machine-learning models for discriminating between benign and malignant adnexal masses were built using one image per tumor, with 5-fold cross-validation for hyperparameter tuning, and were tested on the validation set. The variables used in model building were patient age, serum CA 125 level and the radiomics features that differed significantly between benign and malignant tumors (determined using the Mann-Whitney U-test with Benjamini-Hochberg correction) and were not redundant based on Pearson correlation analysis. Histology was the reference standard. We assessed the discriminative performance of the radiomics models using the area under the receiver-operating-characteristics curve (AUC) and classification performance using sensitivity and specificity at the optimal cut-off of each model to classify the mass as malignant, as determined by Youden's index. The diagnostic performance of the developed radiomics models was compared with that of the ADNEX model (AUC, sensitivity and specificity at the 10% risk-of-malignancy cut-off, which is the recommended threshold for clinical use of the ADNEX model). RESULTS: In total, 4501 patients met the inclusion criteria. Among these, 2428 patients were excluded owing to an absence of ultrasound images or images unsuitable for radiomics analysis. Overall, a total of 2073 patients were included in the analysis, of whom 803 (38.7%) had a histologically confirmed malignant tumor. In the validation set (n = 622, including 254 malignancies), the clinical-radiomics model trained using the eXtreme Gradient Boosting algorithm, including age, serum CA 125 level and 14 selected radiomics features, achieved the highest performance, with an AUC of 0.89 (95% CI, 0.86-0.92), sensitivity of 0.83 (95% CI, 0.79-0.88) and specificity of 0.81 (95% CI, 0.77-0.85) at the optimal cut-off (31% risk of malignancy, based on Youden's index). At a 10% risk-of-malignancy cut-off, it had a sensitivity of 0.94 (95% CI, 0.91-0.97) and specificity of 0.48 (95% CI, 0.42-0.53). The ADNEX model had an AUC of 0.95 (95% CI, 0.93-0.97), sensitivity of 0.97 (95% CI, 0.95-0.99) and specificity of 0.72 (95% CI, 0.68-0.77) at the 10% risk-of-malignancy cut-off in the validation set. CONCLUSIONS: Our results support further exploration of radiomics analysis for distinguishing between benign and malignant adnexal masses in larger study populations. Future studies should consider using multiple images per tumor and testing alternative model-building methods, and should perform external validation to assess the generalizability of the radiomics models. © 2026 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Moro F, Ciancia M, Berardino SD, et al. Developing and validating ultrasound-based machine-learning models incorporating radiomics features to predict malignancy in adnexal masses. Ultrasound Obstet Gynecol. 2026. PMID: 41906961. doi:10.1002/uog.70203
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。